Skip to main content
Livermore
Livermore
ZHEN

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
57
Value
$996
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202657$996<0.1%00.0%UnchangedHolders
Q1 202657$1.06K<0.1%00.0%UnchangedHolders
Q4 202557$889<0.1%00.0%UnchangedHolders
Q3 202557$834<0.1%−29−33.7%ReducedHolders
Q2 202586$1.33K<0.1%−59−40.7%ReducedHolders
Q1 2025145$2.16K<0.1%00.0%UnchangedHolders
Q4 2024145$1.92K<0.1%00.0%UnchangedHolders
Q3 2024145$2.06K<0.1%−315−68.5%ReducedHolders
Q2 2024460$5.95K<0.1%00.0%UnchangedHolders
Q1 2024460$6.39K<0.1%+315+217.2%AddedHolders
Q4 2023145$2.07K<0.1%−315−68.5%ReducedHolders
Q3 2023460$7.12K<0.1%00.0%UnchangedHolders
Q2 2023460$7.00K<0.1%00.0%UnchangedHolders
Q1 2023460$8.00K<0.1%+145+46.0%AddedHolders
Q4 2022315$5.00K<0.1%−145−31.5%ReducedHolders
Q3 2022460$6.00K<0.1%00.0%UnchangedHolders
Q2 2022460$6.00K<0.1%00.0%UnchangedHolders
Q1 2022460$7.00K<0.1%00.0%UnchangedHolders
Q4 2021460$6.00K<0.1%00.0%UnchangedHolders
Q3 2021460$8.00K<0.1%00.0%UnchangedHolders
Q2 2021460$8.00K<0.1%−767−62.5%ReducedHolders
Q1 20211,227$22.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.